Lipton, Richard B.
https://orcid.org/0000-0003-2652-2897
Mayo Clinic
Albert Einstein College of Medicine
Citations 145
Assessing Unmet Treatment Needs and Associated Disability in Persons With Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study (P3.10-003)
Reed, Michael L. , Munjal, Sagar , Alam, Aftab, Buse, Dawn C. , Fanning, Kristina M. , Lipton, Richard B. , Schwedt, Todd J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Impact of Migraine Headache Day Frequency on Associated Health: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study (P3.10-001)
Alam, Aftab, Dodick, David, Munjal, Sagar , Fanning, Kristina M. , Reed, Michael L. , Buse, Dawn C. , Schwedt, Todd J. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia (P2.10-025)
Chou, Denise E. , Buse, Dawn C. , Richards, Sharon , Klatt, Jan , Mikol, Daniel D., Cheng, Sunfa , Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data (P2.10-018)
Adams, Aubrey Manack, Silberstein, Stephen D., DeGryse, Ronald E., Dodick, David W. , Lipton, Richard B. , Diener, Hans‐Christoph
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Improved Functionality, Pain Relief, and Satisfaction in Patients Treated With Ubrogepant vs Placebo: Results from 2 Single-Attack Phase 3 Studies, ACHIEVE I and II (P2.10-012)
Viswanathan, Hema N., Shewale, Anand R. , Zhao, Sihui, Trugman, Joel M. , Yu, Sung Yun , Lipton, Richard B. , Ailani, Jessica , Singh, Rashmi B. Halker , Dodick, David W.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Vascular Pathology Is Associated with Rate of Cognitive Decline Independent of AD Pathology (Einstein Aging Study) (P6.222)
Wang, Cuiling , Altschul, Dorothea , Katz, Mindy J. , Ezzati, Ali , Lipton, Richard B. , Dickson, Dennis W. , Derby, Carol A.
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
Perspectives of Adolescents/Young Adults on the Burden of Their Parent’s Migraine: Results from the CaMEO Study (P4.121)
Buse, Dawn C. , Fanning, Kristina M. , Reed, Michael L. , Adams, Aubrey Manack, Powers, Scott W. , Gelfand, Amy A. , VanderPluym, Juliana H. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)
Starling, Amaal J. , Tepper, Stewart J. , Shamim, Ejaz A. , Hindiyeh, Nada , Silberstein, Stephen D., Marmura, Michael J. , Robbins, Matthew S. , Charles, Andrew , Goadsby, Peter J. , Lipton, Richard B. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Dodick, David W. , Goadsby, Peter J. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Cady, Roger, Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available